A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
Clinical trial NCT06700395 · RECRUITING
Trial details
- NCT number
- NCT06700395
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-28
- Primary completion
- 2026-03-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.